Adaptyx Biosciences
PrivateLast Round
Seed
Oct 20, 2025
Total Funding Raised
$14M
Company Overview
Adaptyx Biosciences is a biotechnology company that develops a biowearable platform for continuous, multi-analyte molecular monitoring using synthetic DNA-based molecular switches and AI-powered analytics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptyx Biosciences Comparables
Compare Adaptyx Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Level Zero Health | 87% | |
| Aptec Health | 83% | |
| Nutromics | 82% |
Adaptyx Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 20, 2025 |
Key People
Founding team and executive leadership
Adaptyx Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Interlagos Capital | Seed |
| Starbloom Capital | Seed |
| Cantos Ventures | Seed |
| Stanford University | Seed |
| Humba Ventures | Seed |
| Seaside Ventures | Seed |
| Hyperlink Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2025
Grew 30% QoQ, from 10 to 13 employees.
- Oct 22, 2025
Developing a wearable patch for continuous biomarker monitoring.
Recent news
Latest coverage and updates
- is_developingSep 9, 2026
Adaptyx Biosciences, Inc. is developing continuous cortisol monitor on Jul 1st '26.
- recognized_asSep 9, 2026
Adaptyx Biosciences, Inc. recognized as first-place win at 2026 Innovation Challenge on Jul 1st '26.
- receives_awardSep 9, 2026
Adaptyx Biosciences, Inc. received award Innovation Challenge at 2026 Innovation Challenge on Sep 9th '26.
Adaptyx Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Adaptyx Biosciences's valuation, stock price, and market status.
Is Adaptyx Biosciences a public or private company?
Adaptyx Biosciences is a private company.
What is the current stock price of Adaptyx Biosciences?
Adaptyx Biosciences is a private company, so its shares have no public market price. Caplight tracks Adaptyx Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adaptyx Biosciences worth (valuation)?
Valuation information for Adaptyx Biosciences is not publicly available.
Can I buy Adaptyx Biosciences stock?
Adaptyx Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adaptyx Biosciences's last funding round?
Adaptyx Biosciences's most recent funding round was Seed on October 20, 2025.
Who are the main investors in Adaptyx Biosciences?
Key investors in Adaptyx Biosciences include Interlagos Capital.
Will Adaptyx Biosciences IPO soon?
No public IPO plans have been announced for Adaptyx Biosciences.
How can I track Adaptyx Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Adaptyx Biosciences's shares on secondary markets.